Literature DB >> 9421303

Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.

D J Prentice1, S L Payne, S M Hourani.   

Abstract

1. In this study we have characterized the receptor(s) in the rat mesenteric artery mediating relaxant responses to adenosine and a number of adenosine analogues, N6-R-phenylisopropyladenosine (R-PIA), N6-cyclopentyladenosine (CPA), N6-(3-iodo-benzyl)-adenosine-5'-N-methyluronamide (IB-MECA) and 5'-N-ethylcarboxamidoadenosine (NECA), by use of the non-selective antagonist 8-sulphophenyltheophylline (8-SPT) and the A2A selective ligands 2-[p-(2-carbonylethyl)-phenylethylamino]-5'-N-ethylcarboxami doadenosine (CGS 21680) and 4-(2-[7-amino-2-(2-furyl)[1,2,4]-triazolo[2,3-a][1,3,5]-triazin-5- ylamino]ethyl) phenol (ZM 241385). We have also studied the effects of endothelial removal and uptake inhibition by nitrobenzylthioinosine (NBTI) and the effects of the A3 receptor antagonist 1,3-dipropyl-8-(4-acrylate)phenylxanthine (BWA1433). 2. Adenosine, NECA, CPA and R-PIA all elicited relaxant responses in tissues precontracted with phenylephrine (1 microM) with the following potency order: NECA > R-PIA > adenosine = CPA. However, E/[A] curves to NECA were biphasic. CGS 21680 was inactive at concentrations up to 30 microM and IB-MECA elicited relaxant responses which were resistant to blockade by 8-SPT and BWA1433 (100 microM). 3. Removal of the endothelium produced a small but significant decrease in the asymptote of the high potency phase of E/[A] curves to NECA with no change in p[A]50. E/[A] curves to adenosine were not altered by removal of the endothelium. However, there were small rightward shifts of E/[A] curves to CPA and R-PIA in the absence of endothelium. 4. Inhibition of uptake by NBTI (1 microM) had no effect on E/[A] curves to NECA, CPA or R-PIA, but E/[A] curves to adenosine were significantly left-shifted in the presence of NBTI. 5. 8-SPT (10-100 microM) caused significant rightward shifts of the high potency phase of the E/[A] curves to NECA (pA2 = 5.63+/-0.26). The second phase of the concentration-response curve to NECA appeared to be resistant to blockade by 8-SPT, as were E/[A] curves for adenosine, CPA or R-PIA. However, in the presence of NBTI (1 microM), 8-SPT (100 microM) gave significant rightward shifts of E/[A] curves to adenosine. 6. ZM 241385 (0.1-1 microM) produced significant rightward shifts of the high potency phase of NECA E/[A] curves (pA2=7.65+/-0.25 in the presence and 7.20+/-0.12 in the absence of endothelium), while curves to R-PIA were not significantly shifted by 1 microM ZM 241385. In the presence of NBTI E/[A] curves to adenosine were significantly rightward shifted by ZM 241385 (0.1 microM, pA2=7.50+/-0.16). 7. In conclusion, the results suggest activation of A2B receptors located primarily on the smooth muscle by low concentrations of NECA and by adenosine under conditions of uptake blockade, and of another, as yet undefined site which may be intracellular, by higher concentrations of NECA, by CPA, R-PIA and adenosine under conditions where uptake is operational.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421303      PMCID: PMC1565082          DOI: 10.1038/sj.bjp.0701524

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Sensitization of visceral afferents to bradykinin in rat jejunum in vitro.

Authors:  A M Brunsden; D Grundy
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

2.  Sympatholytic effect of intravascular ATP is independent of nitric oxide, prostaglandins, Na+ /K+ -ATPase and KIR channels in humans.

Authors:  Christopher M Hearon; Jennifer C Richards; Mathew L Racine; Gary J Luckasen; Dennis G Larson; Michael J Joyner; Frank A Dinenno
Journal:  J Physiol       Date:  2017-07-09       Impact factor: 5.182

3.  A2B adenosine receptors mediate relaxation of the pig intravesical ureter: adenosine modulation of non adrenergic non cholinergic excitatory neurotransmission.

Authors:  M Hernández; M V Barahona; S Bustamante; A García-Sacristán; L M Orensanz
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues.

Authors:  S M Hourani; K Boon; H M Fooks; D J Prentice
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Pharmacological characterisation of the adenosine receptor mediating increased ion transport in the mouse isolated trachea and the effect of allergen challenge.

Authors:  Kristin N Kornerup; Clive P Page; James D Moffatt
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

6.  Functional characterization of coronary vascular adenosine receptors in the mouse.

Authors:  A Flood; J P Headrick
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

7.  Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A₁ and A(2B) adenosine receptors.

Authors:  K H Yip; H Y A Lau; H Wise
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

8.  Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.

Authors:  Bunyen Teng; Daniel Fil; Stephen L Tilley; Catherine Ledent; Thomas Krahn; S Jamal Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

9.  Purinergic receptors in the splanchnic circulation.

Authors:  Manuela Morato; Teresa Sousa; António Albino-Teixeira
Journal:  Purinergic Signal       Date:  2008-04-29       Impact factor: 3.765

10.  A1 and A2A adenosine receptor modulation of alpha 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells.

Authors:  A Preston; M Frydenberg; J M Haynes
Journal:  Br J Pharmacol       Date:  2004-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.